北美淀粉软胶囊市场预测至 2027 年 - COVID-19 影响和应用区域分析（药品、保健品、其他）；分销渠道（超市和大卖场、药房和药店、在线提供商）
No. of Pages: 134 | Report Code: TIPRE00013023 | Category: Life Sciences
No. of Pages: 134 | Report Code: TIPRE00013023 | Category: Life Sciences
淀粉软胶囊通常取自天然来源，被患有各种疾病的患者用作营养补充剂。这些软胶囊通常没有经过基因改造，并且按照严格的质量标准制造。软胶囊有明胶和非明胶两种成分可供选择，适合素食者和非素食者。软胶囊是最常见和广泛使用的药物和营养保健品口服剂型之一。由于素食软胶囊的供应不断增加，淀粉软胶囊市场预计将出现巨大增长。然而，优化用于原料药输送的纤维素/淀粉的困难可能会阻碍市场的增长。
北美淀粉软胶囊市场预计将从 2019 年的 1.3913 亿美元增至 2027 年的 2.0254 亿美元。预计 2020 年至 2027 年该市场将以 4.9% 的复合年增长率增长。推动市场增长的因素包括素食软胶囊的可用性，以及制药和营养保健品公司对软胶囊的偏好不断增加。然而，优化 API 交付的纤维素/淀粉方面的困难可能会对市场增长产生负面影响。
从应用来看，2019年北美淀粉软胶囊市场中保健品细分市场占据较大份额。从分销渠道来看，药房和药店细分市场在北美淀粉软胶囊市场占有较大份额。
一些主要来源在准备北美淀粉软胶囊市场报告时提到的主要和次要来源是世界卫生组织、美国药物研究和制造商以及负责任营养委员会。
购买报告的理由
按分销渠道
Strategic insights for North America Starch Softgel Capsules involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 139.13 Million |
| Market Size by 2027 | US$ 202.54 Million |
| Global CAGR (2020 - 2027) | 4.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 应用
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Starch Softgel Capsules refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Starch Softgel Capsules Market is valued at US$ 139.13 Million in 2019, it is projected to reach US$ 202.54 Million by 2027.
As per our report North America Starch Softgel Capsules Market, the market size is valued at US$ 139.13 Million in 2019, projecting it to reach US$ 202.54 Million by 2027. This translates to a CAGR of approximately 4.9% during the forecast period.
The North America Starch Softgel Capsules Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Starch Softgel Capsules Market report:
The North America Starch Softgel Capsules Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Starch Softgel Capsules Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Starch Softgel Capsules Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Starch Softgel Capsules Market
